Healthcare Finance News November 12, 2024
The focus will be on immunology and cell engineering, with the goal of creating new cancer and autoimmune disease treatments.
The University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery and Innovation, a research center that will focus on immunology and cell engineering with the goal of creating new cancer treatments and autoimmune disease treatments.
The institute will bring together scientists and clinicians to conduct research to that end, with the hope that this will deliver new insights into immunology and cell engineering and fuel the creation of new, rapidly adaptable treatments.
Philanthropic and institutional support of $80 million has helped MD Anderson get the project off the ground.
WHAT’S THE IMPACT?
Cell therapies,...
Today's Sponsors
Today's Sponsor